Skip to main content
Biogened Spolka Akcyjna logo

Biogened Spolka Akcyjna — Investor Relations & Filings

Ticker · BGD ISIN · PLBIOGN00018 LEI · 259400JPC8O2DFHO9887 WAR Manufacturing
Open in API
Filings indexed 245 across all filing types
Latest filing 2026-04-10 Capital/Financing Update
Country PL Poland
Listing WAR BGD

About Biogened Spolka Akcyjna

http://www.biogened.pl

Biogened Spolka Akcyjna is a pharmaceutical company that develops, produces, and distributes dermo-cosmetics, dietary supplements, and medical products. The company's core focus is on its flagship brand, Dermedic, which provides specialized preparations for the care of sensitive and problematic skin. Leveraging extensive pharmaceutical knowledge and close collaboration with dermatologists, Biogened creates innovative, patent-protected solutions. Product formulations are based on unique compositions of active ingredients and incorporate the latest global trends and technologies in dermatology. The company's products are available in numerous international markets.

Recent filings

Filing Released Lang Actions
Zawarcie umowy leasingu operacyjnego - Content (PL)
Capital/Financing Update Classification · 1% confidence The document is an announcement by Biogened S.A. that it has signed an operating lease financing agreement with Santander Leasing S.A. for expanding its vehicle fleet. This is clearly a financing arrangement update rather than a report on financial results, a regulatory report, or a corporate governance matter. It fits the definition of a Capital/Financing Update (CAP).
2026-04-10 Polish
Zawarcie aneksu do umowy o walutowy kredyt inwestycyjny - Content (PL)
Capital/Financing Update Classification · 1% confidence The document is a short announcement (793 characters) from the Management Board ('Zarząd') of Biogened S.A. It details the signing of an annex (amendment) to an existing foreign currency investment loan agreement with Santander Bank Polska S.A., extending the availability period of the loan. This concerns financing activities and capital structure changes. Based on the definitions, this fits best under 'Capital/Financing Update' (CAP). It is not a full report, nor is it a dividend notice, director dealing, or earnings release. Since it is a specific announcement about a financing agreement modification, CAP is the most precise fit over the general RNS fallback.
2024-03-27 Polish
Zawarcie umowy leasingu operacyjnego walutowego - Content (PL)
Capital/Financing Update Classification · 1% confidence The document text, written in Polish, details the execution of 8 operating lease agreements for new vehicles with Santander Leasing S.A. The total financing amount is specified (976,970.54 PLN net) and the term is 48 months. The text explicitly states that this information is considered inside information ('informacja poufna') under MAR regulations because its public disclosure could significantly impact the security price. This transaction relates directly to financing activities and capital structure changes (acquiring assets via leasing). This aligns best with the 'Capital/Financing Update' category (CAP), as it describes a significant financing arrangement entered into by the company.
2024-03-20 Polish
Otrzymanie zawiadomienia o wpisie do rejestru fundacji rodzinnych - Content (PL)
Regulatory Filings Classification · 1% confidence The document text is very short (796 characters) and announces that the Issuer received a notification regarding the registration of a shareholder, ENRAV Fundacji Rodzinnej, in the register of family foundations. It explicitly states that this information is confidential and price-sensitive under MAR regulations. This type of announcement, detailing a change related to a major shareholder or a significant corporate event that is not a standard periodic report (like 10-K or IR), fits best under the general category for regulatory announcements that don't have a more specific code. Since it is not a Director's Dealing (DIRS), Major Shareholding Notification (MRQ - which usually reports crossing a threshold), or a specific legal/financing event, the most appropriate fallback is the general Regulatory Filings category (RNS).
2023-12-29 Polish
Terminowa wypłata dywidendy - Content (PL)
Notice of Dividend Amount Classification · 1% confidence The document text is a formal announcement in Polish by the Management Board ('Zarząd') of Biogened S.A. regarding the payment of a dividend ('dywidendy') for the fiscal year 2022, referencing a resolution from the Annual General Meeting ('Zwyczajnego Walnego Zgromadzenia Akcjonariuszy'). It specifies the total amount paid, the dividend per share (0.40 PLN), and the mechanism of payment via KDPW. This content directly relates to the announcement of dividend details, matching the definition for 'Notice of Dividend Amount'. The document is short (915 chars) and is a direct announcement, not a report itself.
2023-11-17 Polish
Zawarcie aneksu do umowy o walutowy kredyt inwestycyjny - Content (PL)
Capital/Financing Update Classification · 1% confidence The document is very short (797 characters) and announces a specific corporate action: the signing of an annex (amendment) to an existing investment loan agreement with Santander Bank Polska S.A., extending the availability period for a EUR 1,174,000 credit line. This action directly relates to the company's financing and capital structure. Based on the definitions, this fits best under 'Capital/Financing Update' (CAP). It is not a full report, an earnings release, or a management change announcement. Since it is a specific update on financing, CAP is more precise than the general fallback RNS.
2023-09-28 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.